LobbyingAlora Pharmaceuticals lobbying by quarter
Alora Pharmaceuticals's latest lobbying report covers Q2 2026, at $150K. The four quarters Q4 2025–Q3 2026 total $450K. Its first report covers Q3 2023; the issues it reports most are Health Issues.
Alora Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $450K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $50K | 1 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $100K | 1 |
| Q4 2025 | $150K | 1 |
| Q1 2026 | $150K | 1 |
| Q2 2026 | $150K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$760K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
- Food & Drug Administration (FDA)4 reports
- Health & Human Services, Dept of (HHS)4 reports
- White House Office3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Thorn Run Partners | $760K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALEX DELPIZZO | Legislative Director/Legislative Asst, Rep. Ferguson; Staff Asst, House Transportation and Infrastructure Committee | Q2 2026 |
| JESSIE HOWE BRAIRTON | Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee | Q2 2026 |
| STUART CHAPMAN | Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Thorn Run Partners | $150K |
| 04/18for Q1 | Thorn Run Partners | $150K |
| 01/19for Q4 2025 | Thorn Run Partners | $150K |
| 25/10/20for Q3 2025 | Thorn Run Partners | $100K |
| 25/07/16for Q2 2025 | Thorn Run Partners | $40K |
| 25/04/16for Q1 2025 | Thorn Run Partners | $40K |
| 25/01/19for Q4 2024 | Thorn Run Partners | $40K |
| 24/10/17for Q3 2024 | Thorn Run Partners | $40K |
| 24/10/17for Q3 2024 | Thorn Run Partners | Under $5,000 |
| 24/01/17for Q3 2023 | Thorn Run Partners | $50K |
| 23/10/20for Q3 2023 | Thorn Run Partners | $50K |
| 23/10/15for Q3 2023 | Thorn Run Partners | Under $5,000 |